Clinical trial • Ophthalmology
Clinical trial in Retinitis pigmentosa|PDE6A-linked Retinitis Pigmentosa
Clinical trial for Retinitis pigmentosa|PDE6A-linked Retinitis Pigmentosa. None/Not specified-controlled. 9 participants.
Overview
- Trial Therapeutic Area
- Ophthalmology
- Trial Disease
- Retinitis pigmentosa|PDE6A-linked Retinitis Pigmentosa
Key dates
- Initial CTIS Submission Date
- 10-09-2024
- First CTIS Authorization Date
- 24-09-2024
Trial design
None/Not specified-controlled trial across 1 site in Germany.
- Comparator
- None/Not specified
- Target Sample Size
- 9
Recruitment
- Planned Sample Size
- 9
- Recruitment Window Months
- 75
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 9
Germany
- Earliest CTIS Part Ii Submission Date
- 09-09-2024
- Latest Decision Or Authorization Date
- 24-09-2024
- Processing Time Days
- 15
- Number Of Sites
- 1
- Number Of Participants
- 9
Sites
- Site Name
- Universitaetsklinikum Tuebingen AöR
- Department Name
- Centre for Ophthalmology, University Tübingen
- Contact Person Name
- Dominik Fischer
- Contact Person Email
- dominik.fischer@uni-tuebingen.de
- Number Of Participants
- 9
Sponsor
Primary sponsor
- Full Name
- Universitaetsklinikum Tuebingen AöR
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Germany
Related trials
Other published trials that may interest you.